Sign inJoin waitlistJoin the waitlist

UG

Ursa Glaberman

Physician · CHRISTUS St Vincent Regional Medical Center

Credentials: · · · ·

History

CHRISTUS St Vincent Regional Medical Center
2025–Present

University of Arizona College of Medicine
2009–2011
Internal Medicine
University of Arizona College of Medicine
2006–2009
University of New Mexico School of Medicine
2002–2006
New Mexico State University
1998–2002

Research

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
JAMA Oncology · 2021 · 282 citations
Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+…
American Journal of Physiology-Renal Physiology · 2007 · 114 citations
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research…
Journal of Clinical Oncology · 2021 · 107 citations

BT
Bernard Tawfik
8 papers
Alison Stopeck
7 papers
ZD
Zoneddy Dayao
7 papers
Eve Rodler
4 papers
JN
Jacklyn Nemunaitis
4 papers
William Gradishar
4 papers
AW
Antonio Wolff
3 papers
Ben Park
3 papers
Hope Rugo
3 papers
Joseph Sparano
3 papers
Kathy Miller
3 papers
MR
Melanie Royce
3 papers

Grants

University of New Mexico Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $350.5K · University of New Mexico Health Scis Ctr
2005–2026
The NCI Community Oncology Research Program: The New Mexico NCORP
National Cancer Institute · UG1
PI · $1.7M · University of New Mexico Health Scis Ctr
2014–2025

Clinical trials

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
Principal investigator · Completed
New Mexico Cancer Research Alliance
2015–2018
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Site PI · Recruiting
SWOG Cancer Research Network
2018–2036